These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32441479)

  • 21. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.
    Estrela-Lima A; Araújo MS; Costa-Neto JM; Teixeira-Carvalho A; Barrouin-Melo SM; Cardoso SV; Martins-Filho OA; Serakides R; Cassali GD
    BMC Cancer; 2010 Jun; 10():256. PubMed ID: 20525350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A statistical assessment of the biological relationship between simultaneous canine mammary tumours.
    Gunnes G; Borge KS; Lingaas F
    Vet Comp Oncol; 2017 Jun; 15(2):355-365. PubMed ID: 26452754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary cancer in the dog: a study of 120 cases.
    Mulligan RM
    Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
    Pecile A; Groppetti D; Ferrari R; Grieco V; Giudice C; Spediacci C; Stefanello D; Boracchi P
    Res Vet Sci; 2021 Mar; 135():153-161. PubMed ID: 33524825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of low-dose desmopressin in improving hypothermia-induced impairment of primary haemostasis under influence of aspirin - a randomized controlled trial.
    Tsui PY; Cheung CW; Lee Y; Leung SW; Ng KF
    BMC Anesthesiol; 2015 May; 15():80. PubMed ID: 26017715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas.
    Raposo-Ferreira TMM; Brisson BK; Durham AC; Laufer-Amorim R; Kristiansen V; Puré E; Volk SW; Sorenmo K
    Vet Pathol; 2018 Sep; 55(5):622-633. PubMed ID: 29788797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor-positive canine mammary carcinomas.
    Guil-Luna S; Millán Y; De Andres J; Rollón E; Domingo V; García-Macías J; Sánchez-Céspedes R; Martín de Las Mulas J
    Vet Comp Oncol; 2017 Jun; 15(2):391-399. PubMed ID: 26781329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
    Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
    Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumours.
    Szczubiał M; Łopuszyński W; Dąbrowski R; Bochniarz M; Brodzki P
    Pol J Vet Sci; 2022 Jun; 25(2):317-324. PubMed ID: 35861995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
    Ray S; Ray A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010338. PubMed ID: 27841443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
    Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Arginine Vasopressin Type 2 Receptor in Canine Mammary Tumours: Preliminary Results.
    Benavente MA; Bianchi CP; Aba MA
    J Comp Pathol; 2020 Aug; 179():36-40. PubMed ID: 32958145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
    Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.